Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Vicarious Surgical (RBOT) EPS (Basic) (2020 - 2025)

Vicarious Surgical (RBOT) reported EPS (Basic) of -$1.86 for Q3 2025, up 35.86% year-over-year from -$1.37 in Q3 2024, and up 16.59% on a QoQ basis from -$2.23 in Q2 2025.

Vicarious Surgical (RBOT) has 6 years of EPS (Basic) data on file, last reported at -$1.86 in Q3 2025.

  • Quarterly EPS (Basic) rose 35.86% year-over-year to -$1.86 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$6.69 (up 37.71% YoY) and the FY2024 annual result came in at -$10.74, up 26.44% from the prior year.
  • EPS (Basic) climbed to -$1.86 in Q3 2025 per RBOT's latest filing, from -$2.23 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.35 in Q1 2022 and bottomed at -$3.62 in Q2 2023.
  • The 5-year median for EPS (Basic) is -$1.83 (2023), against an average of -$1.39.
  • The widest annual swing landed in 2022, when EPS (Basic) soared 683.33%; it then sank 36100.0% in 2023.
  • Tracing RBOT's EPS (Basic) over 5 years: stood at $0.28 in 2021, then slumped by 135.71% to -$0.1 in 2022, then slumped by 1730.0% to -$1.83 in 2023, then dropped by 28.42% to -$2.35 in 2024, then increased by 20.85% to -$1.86 in 2025.
  • Per Business Quant, the three latest RBOT EPS (Basic) figures stand at -$1.86 (Q3 2025), -$2.23 (Q2 2025), and -$2.6 (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.62
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.95
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.89
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.90
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.66
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.52
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.85
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 2.25
10 Vicarious Surgical - - - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 -1.86
Jun 30, 2025 -2.23
Mar 31, 2025 -2.60
Dec 31, 2024 -2.35
Sep 30, 2024 -2.90
Jun 30, 2024 -2.59
Mar 31, 2024 -2.90
Dec 31, 2023 -1.83
Sep 30, 2023 -3.04
Jun 30, 2023 -3.62
Mar 31, 2023 -0.21
Dec 31, 2022 -0.10
Sep 30, 2022 -0.20
Jun 30, 2022 -0.01
Mar 31, 2022 0.35
Dec 31, 2021 0.28
Sep 30, 2021 -0.49
Jun 30, 2021 -0.08
Mar 31, 2021 -0.06
Dec 31, 2020 -1.17
Sep 30, 2020 -0.04
Jun 30, 2020 0.00